市場調査レポート
商品コード
1252566

デジタルセラピューティクスの世界市場- 構成要素別(ソフトウェア、デバイス)、用途別(糖尿病、肥満、心血管、精神・行動健康、高血圧、不眠症)、販売チャネル別(B2B、B2C)、地域別-2032年までの予測

Digital Therapeutics Market - By Component (Software, Device), By Application (Diabetes, Obesity, Cardiovascular, Mental & Behavioural Health, Hypertension, Insomnia), By Sales Channel (B2B, B2C), By Region - Global Forecast to 2032

出版日: | 発行: Global Market Insights Inc. | ページ情報: 英文 169 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.09円
デジタルセラピューティクスの世界市場- 構成要素別(ソフトウェア、デバイス)、用途別(糖尿病、肥満、心血管、精神・行動健康、高血圧、不眠症)、販売チャネル別(B2B、B2C)、地域別-2032年までの予測
出版日: 2023年03月15日
発行: Global Market Insights Inc.
ページ情報: 英文 169 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

デジタルセラピューティクスの世界市場は、ヘルスケア分野におけるデジタルセラピューティクスの急速な普及と、より質の高い医療を提供できる可能性から、2032年まで順調に拡大すると予想されています。

また、デジタルセラピューティクス・ソリューションがヘルスケア提供の重要な一部となったことから、市場収益は大幅に増加すると予想されています。また、技術の進歩、企業の研究への多額の投資、慢性疾患の治療を奨励する世界の政府のキャンペーンなども、この拡大に寄与しています。

例えば、Teladoc Health社は、2022年2月に慢性疾患管理システムであるChronic Care Completeを発売しました。このシステムは、コネクテッドヘルスモニタリングシステムを活用し、幅広い治療プログラムを提供することで、ヘルスコーチ、医師、メンタルヘルス専門家へのアクセスを拡大します。また、この戦略的な発売により、企業は競合他社をリードすることができ、収益を上げることができます。

デジタルセラピューティクス市場は、コンポーネント、アプリケーション、販売チャネル、地域の観点で分割されています。

コンポーネントでは、デバイス分野が予測期間を通じて大きな市場シェアを獲得すると推測されます。慢性疾患の管理における重要な機能により、デジタル治療機器は受け入れられつつあり、これがこの注目すべきセグメント拡大の主な要因となっています。デジタル自動血糖測定器は、血糖値が範囲内または範囲外であることを即座に表示します。Bluetooth対応、同期モバイルアプリ、小型でスリムなデザインにより、顧客は自分の健康についてより賢い判断を下し、予防のための新しい可能性を手に入れることができます。

アプリケーション別に見ると、精神・行動衛生分野は2023年から2032年にかけて34%以上のCAGRで成長すると予想されています。この急成長は、精神疾患を抱える患者数が多いこと、行動・メンタルヘルス治療に対する研究開発費の支出が大きいことが理由とされています。メンタルヘルスソリューションの需要は、満たされていない医療ニーズやパンデミック対策によるストレスによって促されています。

地域別では、欧州のデジタルセラピューティクス市場は、本調査期間中に堅調に拡大すると予想されています。この地域の市場開拓は、デジタルセラピューティクスへのアクセスの向上、DTxのような最先端の治療法に対応するための個別規制の枠組み構築、政府の支援策、利用率の上昇、デジタルセラピューティクス分野のハイテク新興企業に出資するエンジェル投資家の流入などの要因によって推進されています。

デジタルセラピューティクス市場の競合情勢は、かなり確立されています。この業界で活動している主な競合他社には、Virta Health Corp.、Omada Health、Akili Interactive Labs、Biofourmis, Inc.、Lark Health、などがあります。

目次

第1章 調査手法とスコープ

第2章 エグゼクティブサマリー

第3章 デジタルセラピューティクス業界洞察

  • 業界別セグメンテーション
  • 業界情勢、2018-2032年
  • 業界への影響要因
    • 促進要因
      • 慢性疾患の増加
      • コスト抑制のニーズが高まる
      • ケア提供の質を向上させる可能性
      • デジタルセラピューティクスの普及が進む
    • 業界の潜在的リスク&課題
      • セキュリティとプライバシーの問題
      • 熟練したITプロフェッショナルの不足
  • 成長性分析
    • コンポーネント別
    • アプリケーション別
    • 販売チャネル別
  • COVID-19影響分析
  • デジタルヘルス、デジタルメディスン、デジタルセラピューティックの違い
  • 規制状況について
    • 米国
    • 欧州
  • 償還シナリオ
    • 米国
    • 欧州
  • 投資概要
  • 技術動向の分析
  • デジタルセラピューティクス主要企業の研究開発パイプライン
  • 治療分野ごとのデジタルセラピューティクス使用事例と応用例
  • デジタルセラピューティクスが主要な利害関係者に与える影響
  • デジタルセラピューティクス-バイオファーマ案件、2019年版
  • ポーター分析
  • PESTEL分析

第4章 競合情勢、2021年

  • イントロダクション
  • 企業マトリックス分析、2021年
  • 戦略ダッシュボード、2021年

第5章 デジタルセラピューティクス市場:コンポーネント別

  • 主なセグメント動向
  • ソフトウェア
  • デバイス

第6章 デジタルセラピューティクス市場:アプリケーション別

  • 主なセグメント動向
  • 糖尿病
  • 肥満
  • 心血管系
  • メンタル&ビヘイビアヘルス
  • 高血圧症
  • 不眠症
  • その他

第7章 デジタルセラピューティクス市場:販売チャネル別

  • 主なセグメント動向
  • 企業間取引(B2B)
  • 企業対消費者(B2C)

第8章 デジタルセラピューティクス市場:地域別

  • 主な地域動向
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • シンガポール
  • ラテンアメリカ
    • メキシコ
    • ブラジル
  • MEA
    • サウジアラビア
    • 南アフリカ
    • イスラエル

第9章 企業プロファイル

  • Otsuka Holdings Co., Ltd.
  • Propeller Health(ResMed)
  • Virta Health Corp
  • Teladoc Health
  • Pear Therapeutics Inc
  • Omada Health Inc
  • Akili Interactive Labs
  • WellDoc, Inc.
  • Click Therapeutics
  • Biofourmis, Inc.
  • Lark Health
  • LifeScan, Inc.
  • DarioHealth
  • Voluntis
  • My Sugr(Roche)
図表

Data Tables

  • TABLE 1. Global digital therapeutics market, 2018 - 2024 (USD Million)
  • TABLE 2. Global digital therapeutics market, 2025 - 2032 (USD Million)
  • TABLE 3. Global digital therapeutics market, by component, 2018 - 2024 (USD Million)
  • TABLE 4. Global digital therapeutics market, by component, 2025 - 2032 (USD Million)
  • TABLE 5. Global digital therapeutics market, by application, 2018 - 2024 (USD Million)
  • TABLE 6. Global digital therapeutics market, by application, 2025 - 2032 (USD Million)
  • TABLE 7. Global digital therapeutics market, by sales channels, 2018 - 2024 (USD Million)
  • TABLE 8. Global digital therapeutics market, by sales channels, 2025 - 2032 (USD Million)
  • TABLE 9. Global digital therapeutics market, by region, 2018 - 2024 (USD Million)
  • TABLE 10. Global digital therapeutics market, by region, 2025 - 2032 (USD Million)
  • TABLE 11. Industry impact forces
  • TABLE 12. Software market, by region, 2018 - 2024 (USD Million)
  • TABLE 13. Software market, by region, 2025 - 2032 (USD Million)
  • TABLE 14. Devices market, by region, 2018 - 2024 (USD Million)
  • TABLE 15. Devices market, by region, 2025 - 2032 (USD Million)
  • TABLE 16. Diabetes market, by region, 2018 - 2024 (USD Million)
  • TABLE 17. Diabetes market, by region, 2025 - 2032 (USD Million)
  • TABLE 18. Obesity market, by region, 2018 - 2024 (USD Million)
  • TABLE 19. Obesity market, by region, 2025 - 2032 (USD Million)
  • TABLE 20. Cardiovascular market, by region, 2018 - 2024 (USD Million)
  • TABLE 21. Cardiovascular market, by region, 2025 - 2032 (USD Million)
  • TABLE 22. Mental & behavioral health market, by region, 2018 - 2024 (USD Million)
  • TABLE 23. Mental & behavioral health market, by region, 2025 - 2032 (USD Million)
  • TABLE 24. Hypertension market, by region, 2018 - 2024 (USD Million)
  • TABLE 25. Hypertension market, by region, 2025 - 2032 (USD Million)
  • TABLE 26. Insomnia market, by region, 2018 - 2024 (USD Million)
  • TABLE 27. Insomnia market, by region, 2025 - 2032 (USD Million)
  • TABLE 28. Others market, by region, 2018 - 2024 (USD Million)
  • TABLE 29. Others market, by region, 2025 - 2032 (USD Million)
  • TABLE 30. Business-to-business (B2B) market, by region, 2018 - 2024 (USD Million)
  • TABLE 31. Business-to-business (B2B) market, by region, 2025 - 2032 (USD Million)
  • TABLE 32. Business-to-consumers (B2C) market, by region, 2018 - 2024 (USD Million)
  • TABLE 33. Business-to-consumers (B2C) market, by region, 2025 - 2032 (USD Million)
  • TABLE 34. North America digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 35. North America digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 36. North America digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 37. North America digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 38. North America digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 39. North America digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 40. North America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 41. North America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 42. U.S. digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 43. U.S. digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 44. U.S. digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 45. U.S. digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 46. U.S. digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 47. U.S. digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 48. Canada digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 49. Canada digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 50. Canada digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 51. Canada digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 52. Canada digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 53. Canada digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 54. Europe digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 55. Europe digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 56. Europe digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 57. Europe digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 58. Europe digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 59. Europe digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 60. Europe digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 61. Europe digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 62. Germany digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 63. Germany digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 64. Germany digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 65. Germany digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 66. Germany digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 67. Germany digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 68. UK digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 69. UK digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 70. UK digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 71. UK digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 72. UK digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 73. UK digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 74. France digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 75. France digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 76. France digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 77. France digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 78. France digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 79. France digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 80. Italy digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 81. Italy digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 82. Italy digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 83. Italy digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 84. Italy digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 85. Italy digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 86. Spain digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 87. Spain digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 88. Spain digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 89. Spain digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 90. Spain digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 91. Spain digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 92. Asia Pacific digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 93. Asia Pacific digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 94. Asia Pacific digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 95. Asia Pacific digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 96. Asia Pacific digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 97. Asia Pacific digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 98. Asia Pacific digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 99. Asia Pacific digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 100. Japan digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 101. Japan digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 102. Japan digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 103. Japan digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 104. Japan digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 105. Japan digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 106. China digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 107. China digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 108. China digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 109. China digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 110. China digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 111. China digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 112. India digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 113. India digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 114. India digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 115. India digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 116. India digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 117. India digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 118. Australia digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 119. Australia digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 120. Australia digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 121. Australia digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 122. Australia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 123. Australia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 124. Singapore digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 125. Singapore digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 126. Singapore digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 127. Singapore digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 128. Singapore digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 129. Singapore digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 130. Latin America digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 131. Latin America digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 132. Latin America digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 133. Latin America digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 134. Latin America digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 135. Latin America digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 136. Latin America digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 137. Latin America digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 138. Brazil digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 139. Brazil digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 140. Brazil digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 141. Brazil digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 142. Brazil digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 143. Brazil digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 144. Mexico digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 145. Mexico digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 146. Mexico digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 147. Mexico digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 148. Mexico digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 149. Mexico digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 150. MEA digital therapeutics market, by country, 2018 - 2024, (USD Million)
  • TABLE 151. MEA digital therapeutics market, by country, 2025 - 2032, (USD Million)
  • TABLE 152. MEA digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 153. MEA digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 154. MEA digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 155. MEA digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 156. MEA digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 157. MEA digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 158. Saudi Arabia digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 159. Saudi Arabia digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 160. Saudi Arabia digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 161. Saudi Arabia digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 162. Saudi Arabia digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 163. Saudi Arabia digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 164. South Africa digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 165. South Africa digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 166. South Africa digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 167. South Africa digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 168. South Africa digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 169. South Africa digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)
  • TABLE 170. Israel digital therapeutics market, by component, 2018 - 2024, (USD Million)
  • TABLE 171. Israel digital therapeutics market, by component, 2025 - 2032, (USD Million)
  • TABLE 172. Israel digital therapeutics market, by application, 2018 - 2024, (USD Million)
  • TABLE 173. Israel digital therapeutics market, by application, 2025 - 2032, (USD Million)
  • TABLE 174. Israel digital therapeutics market, by sales channel, 2018 - 2024, (USD Million)
  • TABLE 175. Israel digital therapeutics market, by sales channel, 2025 - 2032, (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach
  • FIG. 2 Breakdown of primary participants
  • FIG. 3 Digital therapeutics industry 360 degree synopsis, 2018 - 2032
  • FIG. 4 Industry segmentation
  • FIG. 5 Industry landscape, 2018 - 2032 (USD Million)
  • FIG. 6 Growth potential analysis, by component
  • FIG. 7 Growth potential analysis, by application
  • FIG. 8 Growth potential analysis, by sales channels
  • FIG. 9 Impact of digital therapeutics on key stakeholders
  • FIG. 10 Porter's analysis
  • FIG. 11 PESTEL analysis
  • FIG. 12 Company matrix analysis, 2021
  • FIG. 13 Strategy dashboard, 2021
  • FIG. 14 Key segment trends, by component
  • FIG. 15 Key segment trends, by application
  • FIG. 16 Key segment trends, by sales channels
  • FIG. 17 Key regional trends
目次
Product Code: 5408

Global Digital Therapeutics Market is slated to expand steadily through 2032 owing to the surging adoption of digital therapeutics in the healthcare sector and its potential to deliver better quality of care.

Additionally, the market revenue is anticipated to increase significantly as digital therapeutics solutions have become a vital part of healthcare delivery. The expansion is also being aided by technological advancements, significant corporate investments in research, and worldwide government campaigns encouraging chronic disease treatment.

For instance, Teladoc Health launched Chronic Care Complete, a chronic condition management system, in February 2022. By utilizing connected health monitoring systems and offering a wide selection of treatment programs, the system expands access to health coaches, doctors, and mental health professionals. The strategic launch also enables the corporation to move ahead in its competition, thus increasing its revenue.

The digital therapeutics market has been divided in terms of component, application, sales channel, and region.

With respect to component, the device segment is speculated to gain substantial market share through the forecast period. Due to their critical function in managing chronic illnesses, digital therapeutic devices have grown in acceptance, which is primarily responsible for this noteworthy segmental expansion. The digital automated blood glucose meters display blood glucose readings that are within or outside the range, immediately. With the Bluetooth-ready, sync mobile app and tiny, slim design, customers can make smarter decisions about their health and have access to new possibilities for prevention.

Based on application, the mental & behavioral health segment is anticipated to grow at more than 34% CAGR from 2023 to 2032. The rapid growth is credited to the large patient population with mental illnesses and significant R&D spending on behavioral and mental health treatments. The demand for mental health solutions has been prompted by significant unmet medical requirements and the stress caused by pandemic mitigation steps.

From the regional front, the Europe digital therapeutics market is expected to proliferate robustly over the review timeline. The market potential in this area is being driven by factors such as growing accessibility to digital therapeutics, the development of a personalized regulatory framework to accommodate cutting-edge modalities such as DTx, supportive government initiatives, rising utilization, and an influx of angel investors funding tech startups in the digital therapeutics space.

The competitive landscape of the digital therapeutics market is considerably established. Some of the major competitors operating in the industry include Virta Health Corp., Omada Health, Akili Interactive Labs, Biofourmis, Inc., Lark Health, and more.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market definitions
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Digital therapeutics industry 360 degree synopsis, 2018-2032
  • 2.2 Business trends
    • 2.2.1 Component trends
    • 2.2.2 Application trends
    • 2.2.3 Sales channel trends
    • 2.2.4 Regional trends

Chapter 3 Digital Therapeutics Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2018-2032 (USD Million)
  • 3.3 Industry impact forces
    • 3.3.1 Growth drivers
      • 3.3.1.1 Increasing prevalence of chronic diseases
      • 3.3.1.2 Rising need for cost containment
      • 3.3.1.3 Potential to increase quality of care delivery
      • 3.3.1.4 Growing popularity of digital therapeutics
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Security and privacy issues
      • 3.3.2.2 Lack of skilled IT professionals
  • 3.4 Growth potential analysis
    • 3.4.1 By component
    • 3.4.2 By application
    • 3.4.3 By sales channel
  • 3.5 COVID-19 impact analysis
  • 3.6 Differences between digital health, digital medicine and digital therapeutics
  • 3.7 Regulatory landscape
    • 3.7.1 U.S.
    • 3.7.2 Europe
  • 3.8 Reimbursement scenario
    • 3.8.1 U.S.
    • 3.8.2 Europe
  • 3.9 Investment overview
  • 3.10 Technology trend analysis
  • 3.11 R&D pipeline for leading digital therapeutics companies
  • 3.12 Digital therapeutics use cases per therapeutic area and example applications
  • 3.13 Impact of digital therapeutics on key stakeholders
  • 3.14 Digital Therapeutics-Biopharma deals, 2019
  • 3.15 Porter's analysis
  • 3.16 PESTEL analysis

Chapter 4 Competitive Landscape, 2021

  • 4.1 Introduction
  • 4.2 Company matrix analysis, 2021
  • 4.3 Strategy dashboard, 2021

Chapter 5 Digital Therapeutics Market, By Component

  • 5.1 Key segment trends
  • 5.2 Software
    • 5.2.1 Market size, by region, 2018-2032 (USD Million)
  • 5.3 Device
    • 5.3.1 Market size ,by region, 2018-2032 (USD Million)

Chapter 6 Digital Therapeutics Market, By Application

  • 6.1 Key segment trends
  • 6.2 Diabetes
    • 6.2.1 Market size, by region, 2018-2032 (USD Million)
  • 6.3 Obesity
    • 6.3.1 Market size, by region, 2018-2032 (USD Million)
  • 6.4 Cardiovascular
    • 6.4.1 Market size, by region, 2018-2032 (USD Million)
  • 6.5 Mental & behavioral health
    • 6.5.1 Market size, by region, 2018-2032 (USD Million)
  • 6.6 Hypertension
    • 6.6.1 Market size, by region, 2018-2032 (USD Million)
  • 6.7 Insomnia
    • 6.7.1 Market size, by region, 2018-2032 (USD Million)
  • 6.8 Others
    • 6.8.1 Market size, by region, 2018-2032 (USD Million)

Chapter 7 Digital Therapeutics Market, By Sales channel

  • 7.1 Key segment trends
  • 7.2 Business-to-business (B2B)
    • 7.2.1 Market size, by region, 2018-2032 (USD Million)
  • 7.3 Business-to-consumers (B2C)
    • 7.3.1 Market size, by region, 2018-2032 (USD Million)

Chapter 8 Digital Therapeutics Market, By Region

  • 8.1 Key regional trends
  • 8.2 North America
    • 8.2.1 Market size, by country, 2018-2032 (USD Million)
    • 8.2.2 Market size, by component, 2018-2032 (USD Million)
    • 8.2.3 Market size, by application, 2018-2032 (USD Million)
    • 8.2.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.2.5 U.S.
      • 8.2.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.2.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.2.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.2.6 Canada
      • 8.2.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.2.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.2.6.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.3 Europe
    • 8.3.1 Market size, by country, 2018-2032 (USD Million)
    • 8.3.2 Market size, by component, 2018-2032 (USD Million)
    • 8.3.3 Market size, by application, 2018-2032 (USD Million)
    • 8.3.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.5 Germany
      • 8.3.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.6 UK
      • 8.3.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.7 France
      • 8.3.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.7.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.8 Italy
      • 8.3.8.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.8.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.8.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.3.9 Spain
      • 8.3.9.1 Market size, by component, 2018-2032 (USD Million)
      • 8.3.9.2 Market size, by application, 2018-2032 (USD Million)
      • 8.3.9.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Market size, by country, 2018-2032 (USD Million)
    • 8.4.2 Market size, by component, 2018-2032 (USD Million)
    • 8.4.3 Market size, by application, 2018-2032 (USD Million)
    • 8.4.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.5 Japan
      • 8.4.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.6 China
      • 8.4.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.7 India
      • 8.4.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.7.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.8 Australia
      • 8.4.8.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.8.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.8.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.4.9 Singapore
      • 8.4.9.1 Market size, by component, 2018-2032 (USD Million)
      • 8.4.9.2 Market size, by application, 2018-2032 (USD Million)
      • 8.4.9.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Market size, by country, 2018-2032 (USD Million)
    • 8.5.2 Market size, by component, 2018-2032 (USD Million)
    • 8.5.3 Market size, by application, 2018-2032 (USD Million)
    • 8.5.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.5.5 Mexico
      • 8.5.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.5.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.5.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.5.6 Brazil
      • 8.5.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.5.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.5.6.3 Market size, by sales channel, 2018-2032 (USD Million)
  • 8.6 MEA
    • 8.6.1 Market size, by country, 2018-2032 (USD Million)
    • 8.6.2 Market size, by component, 2018-2032 (USD Million)
    • 8.6.3 Market size, by application, 2018-2032 (USD Million)
    • 8.6.4 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.5 Saudi Arabia
      • 8.6.5.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.5.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.5.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.6 South Africa
      • 8.6.6.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.6.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.6.3 Market size, by sales channel, 2018-2032 (USD Million)
    • 8.6.7 Israel
      • 8.6.7.1 Market size, by component, 2018-2032 (USD Million)
      • 8.6.7.2 Market size, by application, 2018-2032 (USD Million)
      • 8.6.7.3 Market size, by sales channel, 2018-2032 (USD Million)

Chapter 9 Company Profiles

  • 9.1 Otsuka Holdings Co., Ltd.
    • 9.1.1 Business overview
    • 9.1.2 Financial data
    • 9.1.3 Product landscape
    • 9.1.4 Strategic outlook
    • 9.1.5 SWOT analysis
  • 9.2 Propeller Health (ResMed)
    • 9.2.1 Business overview
    • 9.2.2 Financial data
    • 9.2.3 Product landscape
    • 9.2.4 Strategic outlook
    • 9.2.5 SWOT analysis
  • 9.3 Virta Health Corp
    • 9.3.1 Business overview
    • 9.3.2 Financial data
    • 9.3.3 Product landscape
    • 9.3.4 Strategic outlook
    • 9.3.5 SWOT analysis
  • 9.4 Teladoc Health
    • 9.4.1 Business overview
    • 9.4.2 Financial data
    • 9.4.3 Product landscape
    • 9.4.4 Strategic outlook
    • 9.4.5 SWOT analysis
  • 9.5 Pear Therapeutics Inc
    • 9.5.1 Business overview
    • 9.5.2 Financial data
    • 9.5.3 Product landscape
    • 9.5.4 Strategic outlook
    • 9.5.5 SWOT analysis
  • 9.6 Omada Health Inc
    • 9.6.1 Business overview
    • 9.6.2 Financial data
    • 9.6.3 Product landscape
    • 9.6.4 Strategic outlook
    • 9.6.5 SWOT analysis
  • 9.7 Akili Interactive Labs
    • 9.7.1 Business overview
    • 9.7.2 Financial data
    • 9.7.3 Product landscape
    • 9.7.4 Strategic outlook
    • 9.7.5 SWOT analysis
  • 9.8 WellDoc, Inc.
    • 9.8.1 Business overview
    • 9.8.2 Financial data
    • 9.8.3 Product landscape
    • 9.8.4 Strategic outlook
    • 9.8.5 SWOT analysis
  • 9.9 Click Therapeutics
    • 9.9.1 Business overview
    • 9.9.2 Financial data
    • 9.9.3 Product landscape
    • 9.9.4 Strategic outlook
    • 9.9.5 SWOT analysis
  • 9.10 Biofourmis, Inc.
    • 9.10.1 Business overview
    • 9.10.2 Financial data
    • 9.10.3 Product landscape
    • 9.10.4 Strategic outlook
    • 9.10.5 SWOT analysis
  • 9.11 Lark Health
    • 9.11.1 Business overview
    • 9.11.2 Financial data
    • 9.11.3 Product landscape
    • 9.11.4 Strategic outlook
    • 9.11.5 SWOT analysis
  • 9.12 LifeScan, Inc.
    • 9.12.1 Business overview
    • 9.12.2 Financial data
    • 9.12.3 Product landscape
    • 9.12.4 Strategic outlook
    • 9.12.5 SWOT analysis
  • 9.13 DarioHealth
    • 9.13.1 Business overview
    • 9.13.2 Financial data
    • 9.13.3 Product landscape
    • 9.13.4 Strategic outlook
    • 9.13.5 SWOT analysis
  • 9.14 Voluntis
    • 9.14.1 Business overview
    • 9.14.2 Financial data
    • 9.14.3 Product landscape
    • 9.14.4 Strategic outlook
    • 9.14.5 SWOT analysis
  • 9.15 My Sugr (Roche)
    • 9.15.1 Business overview
    • 9.15.2 Financial data
    • 9.15.3 Product landscape
    • 9.15.4 Strategic outlook
    • 9.15.5 SWOT analysis